封面
市場調查報告書
商品編碼
1762327

胎盤市場,規模,佔有率,趨勢,產業分析報告:類別,各用途,各地區,2025年~2034年的市場預測

Placenta Market Size, Share, Trends, Industry Analysis Report: By Type (Porcine, Equine, Ovine, and Others), Application, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Market Forecast, 2025-2034

出版日期: | 出版商: Polaris Market Research | 英文 113 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究,預計到 2034 年,全球胎盤市場規模將達到 14.0487 億美元。該報告深入分析了當前的市場動態,並分析了未來的市場成長。

胎盤組織及其萃取物在生殖醫學中用於促進子宮健康、提高胚胎著床率並增強整體生育能力。接受體外受精 (IVF) 等輔助生殖技術 (ART) 的夫婦越來越多地選擇基於胎盤的治療來提高受孕幾率。臨床研究表明,胎盤萃取物中的生物活性化合物可以改善子宮內膜容受性,從而提高胚胎著床的成功率。由於生活方式改變、壓力和受孕延遲等因素導致不孕不育率持續上升,對胎盤衍生不孕症治療等創新解決方案的需求預計將增長。因此,胎盤在生育治療的應用日益廣泛,促進了胎盤市場的成長。

人們對胎盤在皮膚病學、毛髮學和生殖醫學應用的認識不斷提高,並持續刺激了需求。斑禿越來越普遍,尤其是在女性和某些種族中,這增加了對利用胎盤再生特性的先進療法的需求。正在進行的科學研究正在增強胎盤產品的功效,擴大其在醫療和化妝品領域的應用。

隨著醫療和化妝品行業對胎盤衍生產品的需求不斷增長,胎盤市場正在迅速擴張。從抗衰老護膚到護髮和生育治療,胎盤萃取物的應用正在推動創新和投資。人們對天然、科學支持的解決方案日益增長的偏好,刺激了對胎盤的需求。各公司不斷開發新的配方,推動市場擴張。持續的進步使胎盤市場在美容、健康和保健行業中始終佔據重要地位。

胎盤市場報告重點

按類型劃分,由於豬胎盤用途廣泛且易於獲取,2024年豬胎盤佔據了胎盤市場佔有率的主導地位。豬胎盤因其富含膠原蛋白、蛋白質和活性勝肽,已成為市場上的寶貴資源。

按應用劃分,預計製藥領域在預測期內的複合年增長率最高。在製藥領域,胎盤萃取物因其治療特性而備受研究。其富含生長因子、細胞激素和細胞外囊泡等生物活性分子,使其成為治療應用的有希望的候選材料。

由於對胎盤類化妝品、膳食補充劑和藥品的需求不斷增長等因素,北美在 2024 年佔據了全球胎盤市場收入佔有率的主導地位。

由於肌肉營養不良症等罕見疾病的盛行率上升以及對胎盤補充劑的需求不斷增長,預計未來幾年亞太市場將實現最高的複合年增長率。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場洞察

  • 胎盤- 產業概述
  • 價值鏈分析
  • 胎盤市場動態
    • 促進因素和機會
      • 再生醫學和傷口癒合領域的應用日益增多
      • 胎盤衍生產品創新發展生物製藥
    • 限制與課題
      • 胎盤衍生產品開發成本高
  • 波特五力模型
    • 替代品的威脅:(中~高)
    • 新加入廠商業者的威脅:中~高
    • 從買方議價能力:中~高
    • 供給企業談判力:(中)
    • 競爭企業間的敵對關係:高
  • 大環境分析

第5章 胎盤市場評估:類別

  • 簡介
  • 綿羊
  • 其他

第6章 胎盤市場評估:各用途

  • 簡介
  • 醫藥品
  • 化妝品
  • 補充品
  • 其他

第7章 胎盤市場評估:各地區

  • 簡介
  • 北美胎盤市場
    • 各國
    • 類別
    • 美國的胎盤市場
    • 加拿大胎盤市場
  • 歐洲的胎盤市場
    • 各國
    • 類別
    • 各用途
    • 英國的胎盤市場
    • 法國的胎盤市場
    • 德國的胎盤市場
    • 義大利胎盤市場
    • 西班牙胎盤市場
    • 荷蘭的胎盤市場
    • 俄羅斯的胎盤市場
    • 其他歐洲的胎盤市場
  • 亞太地區的胎盤市場
    • 各國
    • 類別
    • 各用途
    • 中國的胎盤市場
    • 日本胎盤市場
    • 韓國的胎盤市場
    • 印度的胎盤市場
    • 印尼的胎盤市場
    • 馬來西亞的胎盤市場
    • 其他亞太地區的胎盤市場
  • 南美的胎盤市場
    • 各國
    • 類別
    • 各用途
    • 巴西的胎盤市場
    • 墨西哥胎盤市場
    • 阿根廷胎盤市場
    • 其他南美國家的胎盤市場
  • 中東及非洲的胎盤市場
    • 各國
    • 類別
    • 各用途
    • UAE胎盤市場
    • 以色列的胎盤市場
    • 沙烏地阿拉伯的胎盤市場
    • 南非的胎盤市場
    • 其他中東和非洲的胎盤市場

第8章 競爭情形

  • 策略性架構
  • 策略性架構
  • 業者情勢
  • 最近的開發

第9章 企業簡介

  • Japan Natural Laboratories Co., LTD.
  • Japan Bio Products Co. Ltd
  • ALBERT DAVID LIMITED
  • Atlanta Placenta Encapsulation
  • MIMEDX Group, Inc.
  • PURTIER Placenta
  • The Placenta Company
  • Smith+Nephew
  • Mommy made encapsulation
  • Nubloom LLC.
Product Code: PM3162

The global placenta market size is expected to reach USD 1,404.87 million by 2034, according to a new study by Polaris Market Research. The report "Placenta Market Size, Share, Trends, Industry Analysis Report: By Type (Porcine, Equine, Ovine, and Others), Application, and Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Placental tissues and extracts are utilized in reproductive medicine to enhance uterine health, improve embryo implantation rates, and support overall fertility. Couples undergoing assisted reproductive technologies (ART), such as in-vitro fertilization (IVF), are increasingly turning to placenta-based treatments to enhance their chances of conception. Clinical research suggests that bioactive compounds found in placental extracts improve endometrial receptivity, making embryo implantation more successful. As infertility rates continue to rise due to factors such as lifestyle changes, stress, and delayed pregnancies, the need for innovative solutions such as placenta-derived fertility treatments is expected to grow. Thus, the expanding use of the placenta in fertility treatments is contributing to placenta market growth.

The rising awareness of placenta applications in dermatology, trichology, and reproductive medicine continues to fuel demand. With alopecia areata becoming more prevalent, particularly among women and certain ethnic groups, the need for advanced treatments utilizing the placenta's regenerative properties is growing. Ongoing scientific research is enhancing the effectiveness of placenta-based products, broadening their use across medical and cosmetic fields.

The placenta market is expanding rapidly as demand for placenta-derived products grows across the medical and cosmetic industries. From antiaging skincare to hair care and fertility treatments, the use of placental extracts is driving innovation and investment. The increasing preference for natural and scientifically backed solutions is fueling the placenta market demand. Companies are continuously developing new formulations, driving the market expansion. Ongoing advancements keep the market a significant player in the beauty, health, and wellness industries.

Placenta Market Report Highlights

Based on type, the porcine segment dominated the placenta market share in 2024 due to its versatility and availability of porcine placenta. Porcine (pig) placenta is emerging as a valuable resource in the market, owing to its rich composition of collagen, proteins, and bioactive peptides.

The pharmaceuticals segment, by application, is estimated to register the highest CAGR during the forecast period. In the pharmaceutical segment, placental extracts have been explored for their therapeutic properties. The rich composition of bioactive molecules such as growth factors, cytokines, and extracellular vesicles makes placental extracts promising candidates for therapeutic applications.

North America dominated the global placenta market revenue share in 2024 due to factors such as increasing demand for placenta-based cosmetics, health supplements, and pharmaceutical products.

The market in Asia Pacific is expected to register the highest CAGR in the coming years owing to rising prevalence of rare diseases such as muscular dystrophy and growing demand for placenta-based supplements.

A few global key market players are Japan Natural Laboratories Co., Ltd.; Japan Bio Products Co., Ltd.; Albert David Limited; Atlanta Placenta Encapsulation; MIMEDX Group, Inc.; PURTIER Placenta; The Placenta Company; Smith and Nephew; Mommy Made Encapsulation; and Nubloom LLC.

Polaris Market Research has segmented the placenta market report on the basis of type, application, and region:

By Type Outlook (Revenue, USD Million, 2020-2034)

Porcine

Equine

Ovine

Others

By Application Outlook (Revenue, USD Million, 2020-2034)

Pharmaceuticals

Cosmetics

Supplements

Others

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Russia

Italy

Spain

Netherlands

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

Israel

UAE

Rest of Middle East & Africa

Latin America

Brazil

Mexico

Argentina

Rest of Latin America

Table of Contents

Chapter 1. Introduction

  • 1.1 Report Description
    • 1.1.1 Objective of the Study
    • 1.1.2 Market Scope
    • 1.1.3 Assumptions
  • 1.2 Stakeholders

Chapter 2. Research Methodology

  • 2.1 Research Methodology
  • 2.2 Research Scope and Assumptions
  • 2.3 Information Procurement
    • 2.3.1 Purchased Database
    • 2.3.2 Internal Database
    • 2.3.3 Secondary Sources
    • 2.3.4 Third Party Perspective
    • 2.3.5 Primary Research
  • 2.4 Information Analysis
    • 2.4.1 Data Analysis Models
  • 2.5 Market Formulation and Data Visualization
  • 2.6 Data Validation and Publishing (Secondary Sources)

Chapter 3. Executive Summary

Chapter 4. Market Insights

  • 4.1 Placenta - Industry snapshot
  • 4.2 Placenta Market - Value Chain Analysis
  • 4.3 Placenta Market Dynamics
    • 4.3.1 Drivers and Opportunities
      • 4.3.1.1 Expanding Applications in Regenerative Medicine and Wound Healing
      • 4.3.1.2 Growing Placenta-Derived Biopharmaceutical Innovations
    • 4.3.2 Restraints and Challenges
      • 4.3.2.1 High Cost of Placenta-Based Product Development
  • 4.4 Placenta Market - Porter's Five Forces
    • 4.4.1 Threat of Substitutes: (Moderate to High)
    • 4.4.2 Threat of New Entrants: Moderate to High
    • 4.4.3 Bargaining power of buyers: Moderate to High
    • 4.4.4 Bargaining power of suppliers: Moderate
    • 4.4.5 Competitive Rivalry: High
  • 4.5 Placenta Market - PESTLE Analysis

Chapter 5. Placenta Market Assessment, By Type

  • 5.1 Introduction
  • 5.2 Porcine
  • 5.3 Equine
  • 5.4 Ovine
  • 5.5 Others

Chapter 6. Placenta Market Assessment, By Application

  • 6.1 Introduction
  • 6.2 Pharmaceuticals
  • 6.3 Cosmetics
  • 6.4 Supplements
  • 6.5 Others

Chapter 7. Placenta Market Assessment, By Region

  • 7.1 Introduction
  • 7.2 North America Placenta Market
    • 7.2.1 North America Placenta Market, By Country
    • 7.2.2 North America Placenta Market, By Type
      • 7.2.2.1 North America Placenta Market, By Application
    • 7.2.3 US Placenta Market
      • 7.2.3.1 US Placenta Market, By Type
      • 7.2.3.2 US Placenta Market, By Solutions
    • 7.2.4 Canada Placenta Market
      • 7.2.4.1 Canada Placenta Market, By Type
      • 7.2.4.2 Canada Placenta Market, By Application
  • 7.3 Europe Placenta Market
    • 7.3.1 Europe Placenta Market, By Country
    • 7.3.2 Europe Placenta Market, By Type
    • 7.3.3 Europe Placenta Market, By Application
    • 7.3.4 UK Placenta Market
      • 7.3.4.1 UK Placenta Market, By Type
      • 7.3.4.2 UK Placenta Market, By Application
    • 7.3.5 France Placenta Market
      • 7.3.5.1 France Placenta Market, By Type
      • 7.3.5.2 France Placenta Market, By Application
    • 7.3.6 Germany Placenta Market
      • 7.3.6.1 Germany Placenta Market, By Type
      • 7.3.6.2 Germany Placenta Market, By Application
    • 7.3.7 Italy Placenta Market
      • 7.3.7.1 Italy Placenta Market, By Type
      • 7.3.7.2 Italy Placenta Market, By Application
    • 7.3.8 Spain Placenta Market
      • 7.3.8.1 Spain Placenta Market, By Type
      • 7.3.8.2 Spain Placenta Market, By Application
    • 7.3.9 Netherlands Placenta Market
      • 7.3.9.1 Netherlands Placenta Market, By Type
      • 7.3.9.2 Netherlands Placenta Market, By Application
    • 7.3.10 Russia Placenta Market
      • 7.3.10.1 Russia Placenta Market, By Type
      • 7.3.10.2 Russia Placenta Market, By Application
    • 7.3.11 Rest of Europe Placenta Market
      • 7.3.11.1 Rest of Europe Placenta Market, By Type
      • 7.3.11.2 Rest of Europe Placenta Market, By Application
  • 7.4 Asia Pacific Placenta Market
    • 7.4.1 Asia Pacific Placenta Market, By Country
    • 7.4.2 Asia Pacific Placenta Market, By Type
    • 7.4.3 Asia Pacific Placenta Market, By Application
    • 7.4.4 China Placenta Market
      • 7.4.4.1 China Placenta Market, By Type
      • 7.4.4.2 China Placenta Market, By Application
    • 7.4.5 Japan Placenta Market
      • 7.4.5.1 Japan Placenta Market, By Type
      • 7.4.5.2 Japan Placenta Market, By Application
    • 7.4.6 South Korea Placenta Market
      • 7.4.6.1 South Korea Placenta Market, By Type
      • 7.4.6.2 South Korea Placenta Market, By Application
    • 7.4.7 India Placenta Market
      • 7.4.7.1 India Placenta Market, By Type
      • 7.4.7.2 India Placenta Market, By Application
    • 7.4.8 Indonesia Placenta Market
      • 7.4.8.1 Indonesia Placenta Market, By Type
      • 7.4.8.2 Indonesia Placenta Market, By Application
    • 7.4.9 Malaysia Placenta Market
      • 7.4.9.1 Malaysia Placenta Market, By Type
      • 7.4.9.2 Malaysia Placenta Market, By Application
    • 7.4.10 Rest of Asia Pacific Placenta Market
      • 7.4.10.1 Rest of Asia Pacific Placenta Market, By Type
      • 7.4.10.2 Rest of Asia Pacific Placenta Market, By Application
  • 7.5 Latin America Placenta Market
    • 7.5.1 Latin America Placenta Market, By Country
    • 7.5.2 Latin America Placenta Market, By Type
    • 7.5.3 Latin America Placenta Market, By Application
    • 7.5.4 Brazil Placenta Market
      • 7.5.4.1 Brazil Placenta Market, By Type
      • 7.5.4.2 Brazil Placenta Market, By Application
    • 7.5.5 Mexico Placenta Market
      • 7.5.5.1 Mexico Placenta Market, By Type
      • 7.5.5.2 Mexico Placenta Market, By Application
    • 7.5.6 Argentina Placenta Market
      • 7.5.6.1 Argentina Placenta Market, By Type
      • 7.5.6.2 Argentina Placenta Market, By Application
    • 7.5.7 Rest of Latin America Placenta Market
      • 7.5.7.1 Rest of Latin America Placenta Market, By Type
      • 7.5.7.2 Rest of Latin America Placenta Market, By Application
  • 7.6 Middle East and Africa Placenta Market
    • 7.6.1 Middle East and Africa Placenta Market, By Country
    • 7.6.2 Middle East and Africa Placenta Market, By Type
    • 7.6.3 Middle East and Africa Placenta Market, By Application
    • 7.6.4 UAE Placenta Market
      • 7.6.4.1 UAE Placenta Market, By Type
      • 7.6.4.2 UAE Placenta Market, By Application
    • 7.6.5 Israel Placenta Market
      • 7.6.5.1 Israel Placenta Market, By Type
      • 7.6.5.2 Israel Placenta Market, By Application
    • 7.6.6 Saudi Arabia Placenta Market
      • 7.6.6.1 Saudi Arabia Placenta Market, By Type
      • 7.6.6.2 Saudi Arabia Placenta Market, By Application
    • 7.6.7 South Africa Placenta Market
      • 7.6.7.1 South Africa Placenta Market, By Type
      • 7.6.7.2 South Africa Placenta Market, By Application
    • 7.6.8 Rest of Middle East & Africa Placenta Market
      • 7.6.8.1 Rest of Middle East & Africa Placenta Market, By Type
      • 7.6.8.2 Rest of Middle East & Africa Placenta Market, By Application

Chapter 8. Competitive Landscape

  • 8.1 Strategy Framework
  • 8.2 Strategy Framework
  • 8.3 Vendor Landscape
  • 8.4 Recent Development

Chapter 9. Company Profiles

  • 9.1 Japan Natural Laboratories Co., LTD.
    • 9.1.1 Business Overview
    • 9.1.2 Products Benchmarking
  • 9.2 Japan Bio Products Co. Ltd
    • 9.2.1 Business Overview
    • 9.2.2 Products Benchmarking
    • 9.2.3 Recent Developments
  • 9.3 ALBERT DAVID LIMITED
    • 9.3.1 Business Overview
    • 9.3.2 Financial Snapshot
      • 9.3.2.1 Total Income by Region
    • 9.3.3 Products Benchmarking
    • 9.3.4 Recent Developments
  • 9.4 Atlanta Placenta Encapsulation
    • 9.4.1 Business Overview
    • 9.4.2 Products Benchmarking
  • 9.5 MIMEDX Group, Inc.
    • 9.5.1 Business Overview
    • 9.5.2 Financial Snapshot
    • 9.5.3 Products Benchmarking
    • 9.5.4 Recent Developments
  • 9.6 PURTIER Placenta
    • 9.6.1 Business Overview
    • 9.6.2 Products Benchmarking
  • 9.7 The Placenta Company
    • 9.7.1 Business Overview
    • 9.7.2 Products and Services
  • 9.8 Smith+Nephew
    • 9.8.1 Business Overview
    • 9.8.2 Financial Snapshot
      • 9.8.2.1 Net Sales by Market Segment
    • 9.8.3 Products and Services
  • 9.9 Mommy made encapsulation
    • 9.9.1 Business Overview
    • 9.9.2 Products Benchmarking
  • 9.10 Nubloom LLC.
    • 9.10.1 Business Overview
    • 9.10.2 Products Benchmarking

List of Tables

  • Table 1 Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 2 Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 3 Placenta Market Assessment, By Geography, 2021 - 2034 (USD Million)
  • Table 4 North America Placenta Market, By Country, 2021 - 2034 (USD Million)
  • Table 5 North America Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 6 North America Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 7 US Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 8 US Placenta Market, By Solutions, 2021 - 2034 (USD Million)
  • Table 9 Canada Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 10 Canada Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 11 Europe Placenta Market, By Country, 2021 - 2034 (USD Million)
  • Table 12 Europe Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 13 Europe Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 14 UK Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 15 UK Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 16 France Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 17 France Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 18 Germany Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 19 Germany Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 20 Italy Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 21 Italy Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 22 Spain Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 23 Spain Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 24 Netherlands Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 25 Netherlands Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 26 Russia Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 27 Russia Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 28 Rest of Europe Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 29 Rest of Europe Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 30 Asia Pacific Placenta Market, By Country, 2021 - 2034 (USD Million)
  • Table 31 Asia Pacific Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 32 Asia Pacific Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 33 China Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 34 China Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 35 Japan Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 36 Japan Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 37 South Korea Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 38 South Korea Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 39 India Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 40 India Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 41 Indonesia Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 42 Indonesia Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 43 Malaysia Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 44 Malaysia Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 45 Rest of Asia Pacific Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 46 Rest of Asia Pacific Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 47 Latin America Placenta Market, By Country, 2021 - 2034 (USD Million)
  • Table 48 Latin America Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 49 Latin America Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 50 Brazil Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 51 Brazil Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 52 Mexico Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 53 Mexico Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 54 Argentina Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 55 Argentina Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 56 Rest of Latin America Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 57 Rest of Latin America Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 58 Middle East and Africa Placenta Market, By Country, 2021 - 2034 (USD Million)
  • Table 59 Middle East and Africa Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 60 Middle East and Africa Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 61 UAE Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 62 UAE Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 63 Israel Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 64 Israel Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 65 Saudi Arabia Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 66 Saudi Arabia Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 67 South Africa Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 68 South Africa Placenta Market, By Application, 2021 - 2034 (USD Million)
  • Table 69 Rest of Middle East & Africa Placenta Market, By Type, 2021 - 2034 (USD Million)
  • Table 70 Rest of Middle East & Africa Placenta Market, By Application, 2021 - 2034 (USD Million)

List of Figures

  • Figure 1. Information Procurement
  • Figure 2. Primary Research Pattern
  • Figure 3. Primary research process
  • Figure 4. Market research approaches - Bottom-Up Approach
  • Figure 5. Market research approaches - Top-Down Approach
  • Figure 6. Market research approaches - Combined Approach
  • Figure 7. Executive Summary
  • Figure 8. Market by Region, 2024 (USD Million)
  • Figure 9. Placenta Market, 2021 - 2034 (USD Million)
  • Figure 10. Value Chain Analysis
  • Figure 11. Porter's Five Forces
  • Figure 12. PESTLE Analysis
  • Figure 13. Market, By Type
  • Figure 14. Placenta Market, By Type, 2024 & 2034 (USD Million)
  • Figure 15. Placenta Market, By Porcine, 2021 - 2034 (USD Million)
  • Figure 16. Placenta Market, By Equine, 2021 - 2034 (USD Million)
  • Figure 17. Placenta Market, By Ovine, 2021 - 2034 (USD Million)
  • Figure 18. Placenta Market, By Others, 2021 - 2034 (USD Million)
  • Figure 19. Market, By Application
  • Figure 20. Placenta Market, By Application, 2024 & 2034 (USD Million)
  • Figure 21. Placenta Market, By Pharmaceuticals, 2021 - 2034 (USD Million)
  • Figure 22. Placenta Market, By Cosmetics, 2021 - 2034 (USD Million)
  • Figure 23. Placenta Market, By Supplements, 2021 - 2034 (USD Million)
  • Figure 24. Placenta Market, By Others, 2021 - 2034 (USD Million)
  • Figure 25. Placenta Market Assessment, By Geography, 2024 & 2034 (USD Million)